<DOC>
	<DOCNO>NCT00001652</DOCNO>
	<brief_summary>The purpose research protocol screen enroll individual bipolar disorder track person 's course illness order study long-term course illness elucidate possible clinical biological predictor acute sustain treatment response . As part protocol , subject : systematically administer psychiatric rating scale life-chart method ( LCM ) daily assessment mood , sleep , behavior ; ask participate non-invasive research procedure , blood draw measurement thyroid antibody intracellular calcium ; medicate clinically appropriate . This protocol also serve step stone protocol comparative acute long-term efficacy three antidepressant ( # 95-M-0129 ) , efficacy omega-3 fatty acid ( # 00-M-0004 ) , separate write informed consent obtain . Patients study participant large NIMH-Stanley Foundation Bipolar Network ( SFBN ) , involve six academic site focus well understand long-term course treatment illness . The current protocol thus serve entry point individual bipolar disorder screen detailed longitudinal assessment prior formal blind randomize IRB approve treatment protocol .</brief_summary>
	<brief_title>The Evaluation Follow-up Patients With Bipolar Disorder</brief_title>
	<detailed_description>The purpose research protocol screen enroll individual bipolar disorder track person 's course illness order study long-term course illness elucidate possible clinical biological predictor acute sustain treatment response . As part protocol , subject : systematically administer psychiatric rating scale life-chart method ( LCM ) daily assessment mood , sleep , behavior ; ask participate non-invasive research procedure , blood draw measurement thyroid antibody intracellular calcium ; medicate clinically appropriate . This protocol also serve step stone protocol comparative acute long-term efficacy three antidepressant ( # 95-M-0129 ) , efficacy omega-3 fatty acid ( # 00-M-0004 ) , separate write informed consent obtain . Patients study participant large NIMH-Stanley Foundation Bipolar Network ( SFBN ) , involve six academic site focus well understand long-term course treatment illness . The current protocol thus serve entry point individual bipolar disorder screen detailed longitudinal assessment prior formal blind randomize IRB approve treatment protocol .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Subjects must fulfill DSMIV criterion Bipolar I disorder ( BPI ) , Bipolar II disorder ( BPII ) , Bipolar Disorder otherwise specify ( BPNOS ) , schizoaffective disorder bipolar type . Subjects must competent comprehend purpose study provide write informed consent willing participate detail longitudinal followup . Subjects undergo complete psychiatric diagnostic interview ( SCIDDSMIV ) , medical , neurological , laboratory examination ( appropriate EKG , renal liver function test , serum electrolyte , urinalysis , HIV , hepatitis B , pregnancy testing , urine drug screen presence psychoactive drug drug abuse ) . Subjects must least 18 year old . Subjects general medical illness primary ( i.e . appear cause mood disorder ) , contraindicate use conventional study medication protocol . Women participant child bear potential must nongravid , nonnursing , use acceptable method birth control intrauterine device , diaphragm contraceptive foam , condom spermicide . Subjects must alcohol substance use dependence sufficient magnitude require independent , concurrent treatment intervention ( exclude selfhelp group ) , i.e. , hospitalization , day treatment program , counselor visit .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2002</verification_date>
	<keyword>Life-Charting</keyword>
	<keyword>Cerebrospinal Fluid</keyword>
	<keyword>Diagnostic Tests</keyword>
	<keyword>Cognitive Testing</keyword>
	<keyword>Course Illness</keyword>
	<keyword>Bipolar Disorder</keyword>
</DOC>